News

Employers should be focusing beyond Blue Monday, 20 January 2025, and ensuring mental health is given enough attention and support throughout the year, according to Towergate Employee Benefits.

The Government has injected £60 million in funding into hundreds of creative businesses and projects as part of its modern Industry Strategy to grow the UK economy.

Science and innovation campus, Discovery Park, in Sandwich, Kent has launched applications for the fourth cohort of its immersive business growth competition, ‘Discovery Spark’.

New research from Trainline Partner Solutions, the B2B arm of Trainline, reveals over three quarters of UK SMBs expect to increase both domestic travel volumes (76%) and business travel budgets (79%) in 2025 according to their business travel decision makers.

Elite Business Live is back and bigger than ever for 2025, promising an unforgettable two-day event for ambitious SMEs and fast-growing companies.

Small businesses across the UK are at a financial crossroads as high interest rates, and restricted access to traditional financing, become a growth inhibitor, according to the 2025 Intuit QuickBooks Small Business Index Annual Report.

Small Business Britain has announced the 2025 line-up of the UK’s 100 most dynamic female entrepreneurs as part of its celebrated f:Entrepreneur #iAlso100 campaign.

Entrepreneur and Dragons’ Den investor Steven Bartlett has revealed that declining an opportunity to invest in a company now valued at £40,000,000 stands as his biggest regret from the show.

Tech startups hold significant potential to drive innovation and progress. They also present unique challenges that only investors with expertise in IP are equipped to tackle effectively.

Unreasonable, a new growth marketing agency co-founded by Brad Mac, has launched from cocreatd, the venture studio founded by Oliver Yonchev.

ESG initiatives remain out of reach for the majority of UK businesses, according to ‘The Finance and Business Synergy Report’ by expense management platform, Pleo.

Emitwise and Equipoise have partnered with the SME Climate Hub to provide emissions measurement tools to small and medium-sized enterprises (SMEs). The free tools help businesses measure both operational and supply chain emissions to inform their reduction strategies.

The Department for Business & Trade, Challenge Works, the Open Data Institute, and Smart Data Foundry are calling on innovators to enter the new Smart Data Challenge Prize.

Today, Canva, the all-in-one visual communication platform, unveiled its second annual New Year, New Job report, offering a comprehensive look at how artificial intelligence (AI), social media, and accessible design tools are impacting the hiring process in the UK and beyond.

AI venture capital investment in London has hit an all-time high, making up 32% of overall VC investment in the city according to the latest data from Dealroom and London & Partners. London-headquartered AI startups raised a record $3.5 billion in VC in 2024. This reflects a 52% increase to the levels raised in 2023 ($2.3 billion) and is 21% higher than the previous record set in 2022 ($2.9 billion).

TheHill, an innovation catalyst, embedded within Oxford University Hospitals NHS Foundation Trust has announced a new partnership with regulatory compliance experts, IMed Consultancy, sponsors of its successful NHS Market Access Accelerator Programme.

With more than a quarter of young people eager to set-up a business in 2025, business magnates Sir Richard Branson and Simon Squibb, have partnered up to launch the ‘Elevator of Dreams’ at Virgin Hotels London in Shoreditch.

A think tank has called on the government to continue its investment drive to support AI adoption in private businesses and across public services.

Tech Nation (part of Founders Forum Group), Europe’s AI group Merantix, and Onfido Founder Husayn Kassai, have announced the launch of the London AI Hub, in partnership with Techspace.

Chromatin Bioscience is pleased to announce its ongoing collaboration with EsoBiotec, which has successfully advanced its ESO-T01 in vivo CAR-T candidate into clinical trials.